Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Neumann

Showing results (151-160 of 301) with videos related to

Pageof 31
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
The changing face of the cost-utility literature, 1990-2012Peter J Neumann, Teja Thorat, Jennifer Shi, et al.
International Journal of Technology Assessment in Health Care|May 25, 2023
A review of HTA guidelines on societal and novel value elementsRachel Milstein Breslau, Joshua T Cohen, Jose Diaz, et al.
International Journal of Cardiology|April 17, 2018
Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissionsNatalia Olchanski, Amanda R Vest, Joshua T Cohen, et al.
Israel Journal of Health Policy Research|November 20, 2013
Oncologists' and family physicians' views on value for money of cancer and congestive heart failure careDan Greenberg, Ariel Hammerman, Shlomo Vinker, et al.
Alzheimer Disease and Associated Disorders|November 8, 2016
The Potential Value of β-Amyloid Imaging for the Diagnosis and Management of Dementia: A Survey of CliniciansYue Zhong, Jason Karlawish, Meridith K Johnson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 24, 2018
Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer PatientsYue Zhong, Adriana Valderrama, Jianying Yao, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Which is more valuable, longer survival or better quality of life? Israeli oncologists' and family physicians' attitudes toward the relative value of new cancer and congestive heart failure interventionsDan Greenberg, Ariel Hammerman, Shlomo Vinker, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 28, 2002
Prevalence and impact of medical comorbidity in Alzheimer's diseaseP Murali Doraiswamy, Joel Leon, Jeffrey L Cummings, et al.
Journal of the National Cancer Institute|January 9, 2010
When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncologyDan Greenberg, Craig Earle, Chi-Hui Fang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force reportLouis P Garrison, Peter J Neumann, Pennifer Erickson, et al.
Pageof 31

Showing results (151-160 of 301) with videos related to

Sort By:
Pageof 31
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
The changing face of the cost-utility literature, 1990-2012Peter J Neumann, Teja Thorat, Jennifer Shi, et al.
International Journal of Technology Assessment in Health Care|May 25, 2023
A review of HTA guidelines on societal and novel value elementsRachel Milstein Breslau, Joshua T Cohen, Jose Diaz, et al.
International Journal of Cardiology|April 17, 2018
Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissionsNatalia Olchanski, Amanda R Vest, Joshua T Cohen, et al.
Israel Journal of Health Policy Research|November 20, 2013
Oncologists' and family physicians' views on value for money of cancer and congestive heart failure careDan Greenberg, Ariel Hammerman, Shlomo Vinker, et al.
Alzheimer Disease and Associated Disorders|November 8, 2016
The Potential Value of β-Amyloid Imaging for the Diagnosis and Management of Dementia: A Survey of CliniciansYue Zhong, Jason Karlawish, Meridith K Johnson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 24, 2018
Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer PatientsYue Zhong, Adriana Valderrama, Jianying Yao, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Which is more valuable, longer survival or better quality of life? Israeli oncologists' and family physicians' attitudes toward the relative value of new cancer and congestive heart failure interventionsDan Greenberg, Ariel Hammerman, Shlomo Vinker, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 28, 2002
Prevalence and impact of medical comorbidity in Alzheimer's diseaseP Murali Doraiswamy, Joel Leon, Jeffrey L Cummings, et al.
Journal of the National Cancer Institute|January 9, 2010
When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncologyDan Greenberg, Craig Earle, Chi-Hui Fang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force reportLouis P Garrison, Peter J Neumann, Pennifer Erickson, et al.
Pageof 31